Pulmonary fibrosis lung sounds study

  • Research type

    Research Study

  • Full title

    Feasibility study for gathering lung sound recordings from pulmonary fibrosis patients and healthy controls and classifying disease status using a combination of digital sound device (‘stemoscope’) and machine learning

  • IRAS ID

    318538

  • Contact name

    Michael Gibbons

  • Contact email

    michael.gibbons2@nhs.net

  • Sponsor organisation

    Royal Devon University Healthcare NHS Foundation Trust

  • Duration of Study in the UK

    0 years, 5 months, 30 days

  • Research summary

    This is a study of chest audio recordings obtained using a sound enhancer, in this case a Bluetooth device called a ‘stemoscope’, combined with intelligent computer-processing and analysis. It is being carried out amongst pulmonary fibrosis patients, with the aim of introducing audio monitoring into NHS care to improve diagnosis of pulmonary fibrosis and remote monitoring of disease progression. Currently, there are insufficient respiratory experts and specialist equipment to meet the patient demand, leading to delays in diagnosis and treatment and a shortage of specialist care following diagnosis. In this study we are aiming to make that specialist practice much more available by recording lung sounds and developing software to do the intelligent analysis. Our aim is for respiratory diseases to be diagnosed quickly and easily and also, in future, for patients to be offered the option to monitor how well they are after diagnosis in their own home. The study will involve 50 patients and 10 controls. When participants attend hospital, the research clinician will collect lung sound recordings (each about 20 seconds long) from 6 locations on the front of the chest and 6 locations on the back, while the patient breathes normally. These recordings will be saved, along with routinely gathered clinical data such as lung function results from hospital records, with an anonymous study number. After that they will be transferred securely to the digital analysis platform where they will be stored securely and anonymously for research purposes. No immediate benefits of participation in this study are anticipated. However, research will deliver benefits to others with a similar condition awaiting diagnosis. In the longer term, participants may see benefits in home monitoring of disease.

  • REC name

    London - Bloomsbury Research Ethics Committee

  • REC reference

    22/PR/1701

  • Date of REC Opinion

    8 Feb 2023

  • REC opinion

    Unfavourable Opinion